Retail pharmacy chain CVS Health’s ($CVS) shares are up 81.86% year-to-date despite subsidiary Omnicare’s recent Texas ...

CVS Health shares jump after the company begins offering MMR vaccines across South Carolina pharmacies and clinics post a measles outbreak.

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some ...

CVS is a strong buy now, with rising earnings, solid dividends, and steady growth prospects despite industry challenges. Read ...

CVS Health Corporation (NYSE:CVS) provides healthcare solutions through insurance, pharmacy benefit management, and retail ...

CVS Health raises its 2025 revenue outlook as Bank of America highlights stronger margins, new tech investments, and momentum ...

Shares of diversified healthcare company CVS Health (NYSE:CVS) jumped 3.2% in the morning session after the company raised ...

CVS Health Corporation (NYSE:CVS) is among the cheap healthcare stocks to buy heading into 2026. On December 4, Bernstein ...

CVS Health Corporation is rated a Buy with a strong turnaround driving industry-leading results. Learn more about CVS stock ...

BATON ROUGE, La. (WAFB) - Louisiana has settled two federal lawsuits against CVS Health Corporation and its pharmacy benefit ...

CVS now expects revenue of at least $400 billion for 2025, up from its prior view of at least $397.3 billion. The company now expects adjusted earnings per share of $6.60 to $6.70, the midpoint of ...

Oklahoma AG Gentner Drummond reached a $5M settlement with CVS Caremark over alleged below-cost pharmacy reimbursements.